Predictive Factors for 30-Day Readmission and Increased Healthcare Utilization in Sickle Cell Disease Patients: A Single-Center Comparative Retrospective Study

References

• World Health Organization. Regional committee for Africa; sickle cell disease in the African Region: fifty-sixth session; 2006.
   Google Scholar
• AlHamdan NA, AlMazrou YY, AlSwaidi FM, et al. Premarital screening for thalassemia and sickle cell disease in Saudi Arabia. Genet Med. 2007;9(6):372–377. doi:10.1097/GIM.0b013e318065a9e8
   PubMed Web of Science ®Google Scholar
• Bin Zuair A, Aldossari S, Alhumaidi R, et al. The burden of sickle cell disease in Saudi Arabia: a single-institution large retrospective study. Int J Gen Med. 2023;16:161–171. doi:10.2147/IJGM.S393233
   PubMed Web of Science ®Google Scholar
• Ahmed AE, Alaskar AS, McClish DK, et al. Saudi SCD patients’ symptoms and quality of life relative to the number of ED visits. BMC Emerg Med. 2016;16(1):30. doi:10.1186/s12873-016-0096-z
   PubMedGoogle Scholar
• Benenson I, Jadotte Y, Echevarria M. Factors influencing utilization of hospital services by adult sickle cell disease patients: a systematic review. JBI Evidence Synth. 2017;15(3):765–808.
   Google Scholar
• Serjeant Graham R. The geography of sickle cell disease: opportunities for understanding its diversity. Ann Saudi Med. 1994;14(3):237–246. doi:10.5144/0256-4947.1994.237
   PubMed Web of Science ®Google Scholar
• Kauf TL, Coates TD, Huazhi L, et al. The cost of health care for children and adults with sickle cell disease. Am J Hematol. 2009;84(6):323–327. doi:10.1002/ajh.21408
   PubMed Web of Science ®Google Scholar
• Jonassaint CR, Jones VL, Leong S, et al. A systematic review of the association between depression and health care utilization in children and adults with sickle cell disease. Br J Haematol. 2016;174(1):136–147. doi:10.1111/bjh.14023
   PubMed Web of Science ®Google Scholar
• Thein SL, Howard J. How I treat the older adult with sickle cell disease. Blood. 2018;132(17):1750–1760. doi:10.1182/blood-2018-03-818161
   PubMed Web of Science ®Google Scholar
• Jonassaint CR, Beach MC, Haythornthwaite JA, et al. The association between educational attainment and patterns of emergency department utilization among adults with sickle cell disease. Int J Behav Med. 2016;23(3):300–309.
   PubMed Web of Science ®Google Scholar
• Kidwell K, Albo C, Pope M, et al. Characteristics of sickle cell patients with frequent emergency department visits and hospitalizations. PLoS One. 2021;16(2):e0247324. doi:10.1371/journal.pone.0247324
   PubMed Web of Science ®Google Scholar
• Yue D, Ponce NA, Needleman J, et al. The relationship between educational attainment and hospitalizations among middle-aged and older adults in the United States. SSM Popul Health. 2021;15:100918. doi:10.1016/j.ssmph.2021.100918
   PubMed Web of Science ®Google Scholar
• Gosadi IM, Gohal GA, Dalak AE, et al. Assessment of factors associated with the effectiveness of premarital screening for hemoglobinopathies in the South of Saudi Arabia. Int J Gen Med. 2021;14:3079–3086. doi:10.2147/IJGM.S321046
   PubMed Web of Science ®Google Scholar
• Sharma D, Day ME, Stimpson S-J, et al. Acute vaso-occlusive pain is temporally associated with the onset of menstruation in women with sickle cell disease. J Womens Health. 2019;28(2):162–169. doi:10.1089/jwh.2018.7147
   Web of Science ®Google Scholar
• Day M, Bonnet K, Schlundt DG, DeBaun M, Sharma D. Vaso-occlusive pain and menstruation in sickle cell disease: a focus group analysis. Womens Health Rep. 2020;1(1):36–46.
   Google Scholar
• Carroll CP, Haywood C, Fagan P, et al. The course and correlates of high hospital utilization in sickle cell disease: evidence from a large, urban Medicaid managed care organization. Am J Hematol. 2009;84(10):666–670. doi:10.1002/ajh.21515
   PubMed Web of Science ®Google Scholar
• Tawfic QA, Kausalya R, Alwan DM, et al. Adult sickle cell disease: a five-year experience of intensive care management in a university hospital in Oman. Sultan Qaboos Univ Med J. 2012;12(2):177–183. doi:10.12816/0003110
   PubMedGoogle Scholar
• Darbari DS, Wang Z, Kwak M, et al. Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study. PLoS One. 2013;8(11):e79923. doi:10.1371/journal.pone.0079923
   PubMed Web of Science ®Google Scholar
• Powars DR, Chan LS, Hiti A, et al. Outcome of sickle cell anemia: a 4-decade observational study of 1056 patients. Medicine. 2005;84(6):363–376. doi:10.1097/01.md.0000189089.45003.52
   PubMed Web of Science ®Google Scholar
• Zakaria OM, Buhalim RA, Al Jabr FA, et al. Reasons for hospitalization of sickle cell disease patients in the Eastern Province of Saudi Arabia: a single-center study. Cureus. 2021;13(11):e19299. doi:10.7759/cureus.19299
   PubMed Web of Science ®Google Scholar
• Adesina OO, Neumayr LD. Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management. Hematol Am Soc Hematol Educ Program. 2019;2019(1):351–358. doi:10.1182/hematology.2019000038
   PubMedGoogle Scholar
• Molokie RE, Montminy C, Dionisio C, et al. Opioid doses and acute care utilization outcomes for adults with sickle cell disease: ED versus acute care unit. Am J Emerg Med. 2018;36(1):88–92. doi:10.1016/j.ajem.2017.07.037
   PubMed Web of Science ®Google Scholar
• Jonassaint CR, O’Brien J, Nardo E, et al. Prevalence of substance use disorders in sickle cell disease compared to other chronic conditions: a population-based study of black American Adults. J Gen Intern Med. 2023;38(5):1214–1223. doi:10.1007/s11606-022-07786-w
   PubMed Web of Science ®Google Scholar
• Gotlieb VK, Oo KZ. Marijuana use and sickle cell disease. Blood. 2008;112(11):4826. doi:10.1182/blood.V112.11.4826.4826
   Google Scholar
• Kotila TR, Busari OE, Makanjuola V, et al. Addiction or pseudoaddiction in sickle cell disease patients: time to decide - a case seriES. Ann Ib Postgrad Med. 2015;13(1):44–47.
   PubMedGoogle Scholar
• Ballas SK. Opioids and sickle cell disease: from opium to the opioid epidemic. J Clin Med. 2021;10(3):438. doi:10.3390/jcm10030438
   PubMed Web of Science ®Google Scholar
• Feliu MH, Wellington C, Crawford RD, et al. Opioid management and dependency among adult patients with sickle cell disease. Hemoglobin. 2011;35(5–6):485–494. doi:10.3109/03630269.2011.610914
   PubMed Web of Science ®Google Scholar
• Brandow AM, Carroll CP, Creary S, et al. American society of hematology 2020 guidelines for sickle cell disease: management of acute and chronic pain. Blood Adv. 2020;4(12):2656–2701. doi:10.1182/bloodadvances.2020001851
   PubMed Web of Science ®Google Scholar
• Henu Kumar Verma SL, Bhaskar VKS, Lakkakula BVKS. Lakkakula, Retrospection of the effect of hydroxyurea treatment in patients with sickle cell disease. Acta Haematol Pol. 2018;49(1):1–8. doi:10.2478/ahp-2018-0001
   Google Scholar
• Osunkwo I, Andemariam B, Minniti CP, et al. Impact of sickle cell disease on patientsʼ daily lives, symptoms reported, and disease management strategies: results from the international Sickle Cell World Assessment Survey (SWAY). Am J Hematol. 2021;96(4):404–417. doi:10.1002/ajh.26063
   PubMed Web of Science ®Google Scholar
• Cronin RM, Yang M, Hankins JS, et al. Association between hospital admissions and healthcare provider communication for individuals with sickle cell disease. Hematology. 2020;25(1):229–240. doi:10.1080/16078454.2020.1780737
   PubMed Web of Science ®Google Scholar
• Powell RE, Lovett PB, Crawford A, et al. A multidisciplinary approach to impact acute care utilization in sickle cell disease. Am J Med Qual. 2018;33(2):127–131. doi:10.1177/1062860617707262
   PubMed Web of Science ®Google Scholar
• Lanzkron S, Carroll CP, Hill P, et al. Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis. Am J Hematol. 2015;90(5):376–380. doi:10.1002/ajh.23961
   PubMed Web of Science ®Google Scholar